Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Neuronetics Inc (STIM)

Neuronetics Inc (STIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 104,955
  • Shares Outstanding, K 69,277
  • Annual Sales, $ 74,890 K
  • Annual Income, $ -43,710 K
  • EBIT $ -38 M
  • EBITDA $ -36 M
  • 60-Month Beta 0.87
  • Price/Sales 0.63
  • Price/Cash Flow N/A
  • Price/Book 3.52

Options Overview Details

View History
  • Implied Volatility 400.53% (-211.49%)
  • Historical Volatility 114.67%
  • IV Percentile 89%
  • IV Rank 47.73%
  • IV High 728.52% on 03/13/26
  • IV Low 101.04% on 08/20/25
  • Expected Move (DTE 28) 0.1700 (11.72%)
  • Put/Call Vol Ratio 0.52
  • Today's Volume 100
  • Volume Avg (30-Day) 185
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 7,887
  • Open Int (30-Day) 7,084
  • Expected Range 1.2800 to 1.6200

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.17
  • Number of Estimates 1
  • High Estimate -0.17
  • Low Estimate -0.17
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8000 +81.25%
on 03/17/26
1.5400 -5.84%
on 03/20/26
+0.1600 (+12.40%)
since 02/20/26
3-Month
0.8000 +81.25%
on 03/17/26
2.3100 -37.23%
on 01/23/26
+0.0500 (+3.57%)
since 12/19/25
52-Week
0.8000 +81.25%
on 03/17/26
5.0500 -71.29%
on 03/24/25
-3.4900 (-70.65%)
since 03/20/25

Most Recent Stories

More News
Neuronetics: Q4 Earnings Snapshot

Neuronetics: Q4 Earnings Snapshot

STIM : 1.4500 (-4.29%)
Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37%...

STIM : 1.4500 (-4.29%)
Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve...

STIM : 1.4500 (-4.29%)
Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare...

STIM : 1.4500 (-4.29%)
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth...

STIM : 1.4500 (-4.29%)
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ: STIM) (the “Company” or “Neuronetics”) a vertically integrated, commercial stage, medical technology and healthcare...

STIM : 1.4500 (-4.29%)
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life...

STIM : 1.4500 (-4.29%)
Neuronetics: Q3 Earnings Snapshot

Neuronetics: Q3 Earnings Snapshot

STIM : 1.4500 (-4.29%)
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of...

STIM : 1.4500 (-4.29%)
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the...

STIM : 1.4500 (-4.29%)

Business Summary

Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics,...

See More

Key Turning Points

3rd Resistance Point 1.7333
2nd Resistance Point 1.6367
1st Resistance Point 1.5433
Last Price 1.4500
1st Support Level 1.3533
2nd Support Level 1.2567
3rd Support Level 1.1633

See More

52-Week High 5.0500
Fibonacci 61.8% 3.4265
Fibonacci 50% 2.9250
Fibonacci 38.2% 2.4235
Last Price 1.4500
52-Week Low 0.8000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.